Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b
文献类型:期刊论文
作者 | Ma, Zhiyong1; Cao, Qian1; Xiong, Yong1; Zhang, Ejuan2; Lu, Mengji3 |
刊名 | Vaccines
![]() |
出版日期 | 2018-03-01 |
卷号 | 6期号:1页码:14 |
关键词 | Hepatitis b virus Toll-like receptors Innate immunity Adaptive immunity Immunotherapy |
ISSN号 | 2076-393X |
DOI | 10.3390/vaccines6010006 |
通讯作者 | Lu, mengji(mengji.lu@uni-due.de) |
英文摘要 | Immune defense against infection with the hepatitis b virus (hbv) is complex and involves both host innate and adaptive immune systems. it is well accepted that the development of sufficient hbv-specific t cell and b cell responses are required for controlling an hbv infection. however, the contribution of innate immunity to removing hbv has been explored in recent years. toll-like receptors (tlrs) are recognized as the first line of antiviral immunity because they initiate intracellular signaling pathways to induce antiviral mediators such as interferons (ifns) and other cytokines. recent studies show that the activation of tlr-mediated signaling pathways results in a suppression of hbv replication in vitro and in vivo. however, hbv has also evolved strategies to counter tlr responses including the suppression of tlr expression and the blockage of downstream signaling pathways. antiviral treatment in chronic hbv-infected patients leads to an upregulation of tlr expression and the restoration of its innate antiviral functions. thus, tlr activation may serve as an additional immunotherapeutic option for treating chronic hbv infection in combination with antiviral treatment. |
WOS关键词 | INNATE IMMUNE-RESPONSES ; PLASMACYTOID DENDRITIC CELLS ; CHRONIC HBV INFECTION ; ADJUVANT-CONTAINING VACCINE ; NONPARENCHYMAL LIVER-CELLS ; T-CELLS ; SURFACE-ANTIGEN ; CPG-OLIGODEOXYNUCLEOTIDES ; IN-VIVO ; HEPADNAVIRAL INFECTION |
WOS研究方向 | Immunology ; Research & Experimental Medicine |
WOS类目 | Immunology ; Medicine, Research & Experimental |
语种 | 英语 |
WOS记录号 | WOS:000443917800005 |
出版者 | MDPI |
URI标识 | http://www.irgrid.ac.cn/handle/1471x/2373243 |
专题 | 武汉病毒研究所 |
通讯作者 | Lu, Mengji |
作者单位 | 1.Wuhan Univ, Dept Infect Dis, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China 2.Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China 3.Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45122 Essen, Germany |
推荐引用方式 GB/T 7714 | Ma, Zhiyong,Cao, Qian,Xiong, Yong,et al. Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b[J]. Vaccines,2018,6(1):14. |
APA | Ma, Zhiyong,Cao, Qian,Xiong, Yong,Zhang, Ejuan,&Lu, Mengji.(2018).Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b.Vaccines,6(1),14. |
MLA | Ma, Zhiyong,et al."Interaction between hepatitis b virus and toll-like receptors: current status and potential therapeutic use for chronic hepatitis b".Vaccines 6.1(2018):14. |
入库方式: iSwitch采集
来源:武汉病毒研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。